In response to the FDA guidance document for Babesia, CTS will implement the licensed Grifols Babesia test for samples received on April 20, 2020 at the Charlotte, Dallas, Phoenix, St. Louis and Tampa laboratories. Be watching for details on an upcoming webinar that will provide you with an overview of implementing this testing.
Check out the Communication page for the complete details by clicking the link: Communications
On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Ris...
The FDA Guidance ZIKV video for the webinar held on 08/15/18 has been posted in the Wh...
As winter weather continues to move through parts of the US, we would like to remind you it may be n...
As an organization dedicated to the safety of the world’s blood and plasma supply, Creative Testing...
That’s just one of the reasons that National Blood Donor Month, which has taken place each Jan...
Celebrate National Blood Donor Month throughout January by inviting eligible individuals to donate b...